QIAGEN N.V. (QIA.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:QIA • NL0015002SN0

43.565 EUR
-0.16 (-0.38%)
Last: Feb 5, 2026, 11:29 AM
Fundamental Rating

6

Overall QIA gets a fundamental rating of 6 out of 10. We evaluated QIA against 18 industry peers in the Life Sciences Tools & Services industry. QIA has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. QIA has a decent growth rate and is not valued too expensively. These ratings could make QIA a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year QIA was profitable.
  • QIA had a positive operating cash flow in the past year.
  • In the past 5 years QIA has always been profitable.
  • QIA had a positive operating cash flow in each of the past 5 years.
QIA.DE Yearly Net Income VS EBIT VS OCF VS FCFQIA.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

  • QIA's Return On Assets of 6.19% is fine compared to the rest of the industry. QIA outperforms 72.22% of its industry peers.
  • With a decent Return On Equity value of 11.11%, QIA is doing good in the industry, outperforming 72.22% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 7.44%, QIA is doing good in the industry, outperforming 61.11% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for QIA is below the industry average of 9.98%.
  • The 3 year average ROIC (7.25%) for QIA is below the current ROIC(7.44%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.19%
ROE 11.11%
ROIC 7.44%
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
QIA.DE Yearly ROA, ROE, ROICQIA.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

  • The Profit Margin of QIA (19.58%) is better than 94.44% of its industry peers.
  • In the last couple of years the Profit Margin of QIA has declined.
  • The Operating Margin of QIA (27.02%) is better than 94.44% of its industry peers.
  • QIA's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 64.10%, QIA belongs to the top of the industry, outperforming 94.44% of the companies in the same industry.
  • QIA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 27.02%
PM (TTM) 19.58%
GM 64.1%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
QIA.DE Yearly Profit, Operating, Gross MarginsQIA.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • QIA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for QIA has been reduced compared to 1 year ago.
  • QIA has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for QIA has been reduced compared to a year ago.
QIA.DE Yearly Shares OutstandingQIA.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
QIA.DE Yearly Total Debt VS Total AssetsQIA.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 3.76 indicates that QIA is not in any danger for bankruptcy at the moment.
  • QIA has a better Altman-Z score (3.76) than 72.22% of its industry peers.
  • QIA has a debt to FCF ratio of 4.50. This is a neutral value as QIA would need 4.50 years to pay back of all of its debts.
  • The Debt to FCF ratio of QIA (4.50) is better than 77.78% of its industry peers.
  • A Debt/Equity ratio of 0.45 indicates that QIA is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.45, QIA is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 4.5
Altman-Z 3.76
ROIC/WACC0.85
WACC8.73%
QIA.DE Yearly LT Debt VS Equity VS FCFQIA.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 2.60 indicates that QIA has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 2.60, QIA belongs to the best of the industry, outperforming 94.44% of the companies in the same industry.
  • QIA has a Quick Ratio of 2.30. This indicates that QIA is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.30, QIA belongs to the top of the industry, outperforming 94.44% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.6
Quick Ratio 2.3
QIA.DE Yearly Current Assets VS Current LiabilitesQIA.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 12.41% over the past year.
  • Measured over the past 5 years, QIA shows a small growth in Earnings Per Share. The EPS has been growing by 7.92% on average per year.
  • Looking at the last year, QIA shows a small growth in Revenue. The Revenue has grown by 5.32% in the last year.
  • QIA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.32% yearly.
EPS 1Y (TTM)12.41%
EPS 3Y-7.35%
EPS 5Y7.92%
EPS Q2Q%9.52%
Revenue 1Y (TTM)5.32%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%6.09%

3.2 Future

  • QIA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.41% yearly.
  • The Revenue is expected to grow by 7.12% on average over the next years.
EPS Next Y13.29%
EPS Next 2Y9.93%
EPS Next 3Y9.85%
EPS Next 5Y9.41%
Revenue Next Year5%
Revenue Next 2Y5.54%
Revenue Next 3Y5.77%
Revenue Next 5Y7.12%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
QIA.DE Yearly Revenue VS EstimatesQIA.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
QIA.DE Yearly EPS VS EstimatesQIA.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 20.94, QIA is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Earnings ratio of QIA indicates a somewhat cheap valuation: QIA is cheaper than 66.67% of the companies listed in the same industry.
  • QIA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.25.
  • With a Price/Forward Earnings ratio of 19.06, QIA is valued on the expensive side.
  • Based on the Price/Forward Earnings ratio, QIA is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.50, QIA is valued a bit cheaper.
Industry RankSector Rank
PE 20.94
Fwd PE 19.06
QIA.DE Price Earnings VS Forward Price EarningsQIA.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, QIA is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, QIA is valued a bit cheaper than the industry average as 77.78% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 23.63
EV/EBITDA 15.09
QIA.DE Per share dataQIA.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • QIA has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.58
PEG (5Y)2.65
EPS Next 2Y9.93%
EPS Next 3Y9.85%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.49%, QIA is not a good candidate for dividend investing.
  • QIA's Dividend Yield is a higher than the industry average which is at 0.43.
  • Compared to an average S&P500 Dividend Yield of 1.82, QIA's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.49%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y9.93%
EPS Next 3Y9.85%
QIA.DE Yearly Income VS Free CF VS DividendQIA.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

More info and screens

Find the best dividend stocksShow peers with best dividend

QIAGEN N.V.

FRA:QIA (2/5/2026, 11:29:08 AM)

43.565

-0.16 (-0.38%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-04
Earnings (Next)02-04
Inst Owners85.46%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap9.45B
Revenue(TTM)2.07B
Net Income(TTM)405.37M
Analysts72.5
Price Target46.93 (7.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.49%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.14%
Min EPS beat(2)-2.4%
Max EPS beat(2)2.11%
EPS beat(4)2
Avg EPS beat(4)0.92%
Min EPS beat(4)-3.85%
Max EPS beat(4)7.8%
EPS beat(8)5
Avg EPS beat(8)1.59%
EPS beat(12)8
Avg EPS beat(12)2.59%
EPS beat(16)12
Avg EPS beat(16)5.18%
Revenue beat(2)0
Avg Revenue beat(2)-0.42%
Min Revenue beat(2)-0.72%
Max Revenue beat(2)-0.12%
Revenue beat(4)1
Avg Revenue beat(4)-0.33%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)1.43%
Revenue beat(8)1
Avg Revenue beat(8)-0.6%
Revenue beat(12)2
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)0.46%
PT rev (1m)5.81%
PT rev (3m)4.99%
EPS NQ rev (1m)5.26%
EPS NQ rev (3m)3.23%
EPS NY rev (1m)5.12%
EPS NY rev (3m)4.98%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.93%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)-0.24%
Valuation
Industry RankSector Rank
PE 20.94
Fwd PE 19.06
P/S 5.39
P/FCF 23.63
P/OCF 16.98
P/B 3.06
P/tB 14
EV/EBITDA 15.09
EPS(TTM)2.08
EY4.77%
EPS(NY)2.29
Fwd EY5.25%
FCF(TTM)1.84
FCFY4.23%
OCF(TTM)2.57
OCFY5.89%
SpS8.08
BVpS14.24
TBVpS3.11
PEG (NY)1.58
PEG (5Y)2.65
Graham Number25.81
Profitability
Industry RankSector Rank
ROA 6.19%
ROE 11.11%
ROCE 10.03%
ROIC 7.44%
ROICexc 10.67%
ROICexgc 39.98%
OM 27.02%
PM (TTM) 19.58%
GM 64.1%
FCFM 22.82%
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
ROICexc(3y)9.42%
ROICexc(5y)10.13%
ROICexgc(3y)34.6%
ROICexgc(5y)42.77%
ROCE(3y)9.77%
ROCE(5y)10.73%
ROICexgc growth 3Y-31.24%
ROICexgc growth 5Y-2.41%
ROICexc growth 3Y-13.09%
ROICexc growth 5Y6.48%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
F-Score8
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 4.5
Debt/EBITDA 2.17
Cap/Depr 97.52%
Cap/Sales 8.94%
Interest Coverage 250
Cash Conversion 87.76%
Profit Quality 116.56%
Current Ratio 2.6
Quick Ratio 2.3
Altman-Z 3.76
F-Score8
WACC8.73%
ROIC/WACC0.85
Cap/Depr(3y)78.4%
Cap/Depr(5y)95.94%
Cap/Sales(3y)7.97%
Cap/Sales(5y)9.87%
Profit Quality(3y)273.85%
Profit Quality(5y)189.74%
High Growth Momentum
Growth
EPS 1Y (TTM)12.41%
EPS 3Y-7.35%
EPS 5Y7.92%
EPS Q2Q%9.52%
EPS Next Y13.29%
EPS Next 2Y9.93%
EPS Next 3Y9.85%
EPS Next 5Y9.41%
Revenue 1Y (TTM)5.32%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%6.09%
Revenue Next Year5%
Revenue Next 2Y5.54%
Revenue Next 3Y5.77%
Revenue Next 5Y7.12%
EBIT growth 1Y18.55%
EBIT growth 3Y-9.05%
EBIT growth 5Y9.63%
EBIT Next Year56.53%
EBIT Next 3Y22.14%
EBIT Next 5Y15.78%
FCF growth 1Y71.67%
FCF growth 3Y5.12%
FCF growth 5Y55.1%
OCF growth 1Y52.1%
OCF growth 3Y1.77%
OCF growth 5Y15.28%

QIAGEN N.V. / QIA.DE FAQ

What is the fundamental rating for QIA stock?

ChartMill assigns a fundamental rating of 6 / 10 to QIA.DE.


Can you provide the valuation status for QIAGEN N.V.?

ChartMill assigns a valuation rating of 5 / 10 to QIAGEN N.V. (QIA.DE). This can be considered as Fairly Valued.


How profitable is QIAGEN N.V. (QIA.DE) stock?

QIAGEN N.V. (QIA.DE) has a profitability rating of 7 / 10.


What is the financial health of QIAGEN N.V. (QIA.DE) stock?

The financial health rating of QIAGEN N.V. (QIA.DE) is 8 / 10.


Can you provide the expected EPS growth for QIA stock?

The Earnings per Share (EPS) of QIAGEN N.V. (QIA.DE) is expected to grow by 13.29% in the next year.